Patel Sujal M

Patel Sujal M is listed in filings as CEO at Nautilus Biotechnology, Inc.. This profile follows SEC Form 4 activity through Mar 4, 2026, including purchase activity. Recent filings connect the profile to Nautilus Biotechnology, Inc. (NAUT). The current snapshot covers public activity from Mar 4, 2025 to Mar 4, 2026. Reported amounts are shown as $65.2K to $57.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.